Ilmarinen Mutual Pension Insurance Co Invests $7.16 Million in Cigna Group $CI

Ilmarinen Mutual Pension Insurance Co purchased a new position in Cigna Group (NYSE:CI) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 26,000 shares of the health services provider’s stock, valued at approximately $7,156,000.

Several other institutional investors and hedge funds also recently modified their holdings of CI. Beacon Financial Strategies CORP bought a new position in shares of Cigna Group in the fourth quarter worth $28,000. Lodestone Wealth Management LLC bought a new position in shares of Cigna Group in the fourth quarter worth $32,000. Collier Financial bought a new position in shares of Cigna Group in the third quarter worth $34,000. Creative Financial Designs Inc. ADV grew its stake in shares of Cigna Group by 147.3% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock worth $37,000 after purchasing an additional 81 shares in the last quarter. Finally, Activest Wealth Management grew its stake in shares of Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock worth $38,000 after purchasing an additional 126 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CI. UBS Group increased their price target on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Raymond James Financial set a $340.00 price target on Cigna Group in a research note on Friday, May 1st. Leerink Partners increased their price target on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research note on Friday, February 6th. The Goldman Sachs Group upped their price objective on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Finally, Wells Fargo & Company raised their target price on Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $339.50.

Cigna Group Trading Down 0.4%

Shares of CI stock opened at $284.62 on Friday. The stock has a 50-day simple moving average of $278.07 and a 200 day simple moving average of $276.88. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The stock has a market capitalization of $75.29 billion, a P/E ratio of 12.07, a P/E/G ratio of 1.03 and a beta of 0.30. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter last year, the business posted $6.74 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts expect that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.

Insider Activity

In other news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 205,904 shares of company stock valued at $60,277,068 over the last three months. Insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.